Cenestin
Product Images NDC 54868-5415

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Cenestin (NDC 54868-5415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cenestin® 1.25 mg Packaging Label (1432)

FDA Label Image

Structural Formulae Sodium Estrone Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 01)

FDA Label Image

Structural Formulae Sodium 17α-dihydroequilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 02)

FDA Label Image

Structural Formulae Sodium 17α-estradiol Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 03)

FDA Label Image

Structural Formulae Sodium Equilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 04)

FDA Label Image

Structural Formulae Sodium 17β-dihydroequilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 05)

FDA Label Image

Structural Formulae Sodium Equilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 06)

FDA Label Image

Structural Formulae Sodium 17β-dihydroequilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 07)

FDA Label Image

Structural Formulae Sodium 17β-estradiol Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 08)

FDA Label Image

Structural Formulae Sodium 17α-dihydroequilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 09)

FDA Label Image

Figure 1: Graph Of Mean Plasma Concentration Of Unconjugated Estrogens After A 2 X 0.625 mg Cenestin Dose Under Fasting Conditions (410f9433 98ed 4c3f Abb1 2386296d2f72 10)

This is a graph labeled "Figure 1" that shows the mean plasma concentration of unconjugated estrogens after a 2 x 0.625 mg Cenestin dose under fasting conditions. The graph shows the plasma concentration in pg/mL on the y-axis and time from dosing on the x-axis. The graph also includes two lines representing different estrogens and a baseline.*

FDA Label Image

Figure 2: Graphical Summary Of % Superficial Cells Results In Patients Following 16 Weeks Of Treatment With Cenestin 0.3mg Mean +/- Se (410f9433 98ed 4c3f Abb1 2386296d2f72 11)

The text describes a figure titled "Summary of % Superficial Cells Results in Patients Following 16 Weeks of Treatment with Cenestin 0.3 mg". The figure presents the mean and standard error data for the percentage of superficial cells in patients after 16 weeks of treatment with Cenestin 0.3 mg at various weeks of treatment.*

FDA Label Image

Cenestin® 0.625 mg Packaging Label (4879)

FDA Label Image

Cenestin® 0.45 mg Packaging Label (5415)

This is an advertisement for a medication called "Cenestin" in the form of tablets, with a concentration of 0.45M6. The advertisement appears to be targeting physicians or healthcare professionals, and may be related to total care. No further information is available from this text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.